Attacking the Challenges of Achalasia: GT Capstone’s “G.I. (Mostly) Joes”

“We needed to validate whether or not our device could create the appropriate pressures needed to restore esophageal function in tissue that closely mimics live human tissue… in a safe environment for live tissue where sanitation would not be a concern. The GCMI and T3 Labs team helped prepare the space, tools, and specimen we needed for the validation testing event.”

Dr. Emily Blum, Medical Affairs Liaison for GCMI, Named Emory University Adjunct Assistant Professor

Congratulations to GCMI’s very own: Dr. Emily Blum on her recent advancement within Emory University from Adjunct Clinical Instructor to Adjunct Assistant Professor. The advancement is a testament to Dr. Blum’s commitment to education and clinical research. Emily is instrumental in advancing med tech innovation for GCMI. She works tirelessly to promote GCMI in successfully…

Why GCMI for preclinical testing and bioskills training? Commitment to value.

We know preclinical testing is a substantial commitment of time and treasure for medtech and life science innovators. We also know the most expensive study is the one you have to do twice.   Our response to your request for preclinical work may not be the lowest bottom line price. But please know this: all…

Why GCMI for preclinical testing and bioskills training? Our scientific acumen.

At GCMI and our preclinical testing arm T3 Labs, we take great pride in our scientific acumen. After all, the organization was conceived and designed by translational researchers for medical product developers. Thirst for science: it’s in our DNA.    We won’t turn your project away because it’s too hard, or because we haven’t done…

Georgia Bio Names GCMI, the Saldana Research Group and Georgia Tech 2021 Golden Helix Innovation Award Winner

Georgia Bio, the state’s life science trade association, named GCMI, the Saldana Research Group and Georgia Tech 2021 Golden Helix Innovation Award recipients. The Innovation Award recognizes the department, institution, company or individuals who are forging new ground by thinking outside traditional paradigms to create some unique technology.   In early 2020, U.S. frontline healthcare…

Preclinical testing’s role in the medical device design and development phase

In the context of GCMI’s phase-gated product development, the “Design and Development” phase (also called “Phase 2” at GCMI) typically follows a Project Planning phase (called “Phase 1” at GCMI). At the completion of project planning, innovators have determined what work is required to take the technology from prototype to product. The Design and Development…

Under pressure: cadaveric testing yields initial human organ validation for GT Capstone Expo winners’ minimally invasive treatment for cardiac arrest

There are approximately 292,000 cases of in-hospital cardiac arrest every year for which the survival rate is less than 24 percent. Resuscitative efforts and supporting technologies are ineffective, slow, fatiguing, traumatic and expensive.   As their Fall 2020 Capstone Project, a group of students from the Georgia Tech Schools of Biomedical, Electrical and Mechanical Engineering…

How do you know you are ready for preclinical work? Insights and recording from our latest webinar.

How can medtech, life science and biopharma innovators know their product is ready for preclinical testing? GCMI Design and Development Director Mike Fisher and Preclinical Program Director Evan Goldberg joined Renovo Biomedical’s Anna Fallon on January 14, 2021 to answer that question.